 The Wall Street Journal reported that Merck Co Inc NYSE: MRK is in advanced talks to acquire Acceleron Pharma Inc NASDAQ: XLRN, citing people familiar with the matter. The deal for Acceleron, which has a market value of around 11 billion, could be announced this week, assuming talks dont fall apart, the people said. 